185
Views
62
CrossRef citations to date
0
Altmetric
Research Article

The Comparison of Antibody Response to Influenza Vaccination in Continuous Ambulatory Peritoneal Dialysis, Hemodialysis and Renal Transplantation Patients

, , , , , & show all
Pages 71-76 | Published online: 09 Jul 2009

  • Douglas RG. Drug therapy: prophylaxis and treatment of influenza. N Hngl J Med 1990: 322(7): 443-50.
  • Grist RN, Reid D. Influenza immunization. Immunization in practice. 1987: 15: 1068 74.
  • Grotto I. Mandel Y. Green MS, et al. Influenza vaccine etlicacy in young, healthy adults. Clin Infect Dis 1998: 26:913-7.
  • Hall CB. Influenza. Pediatrics 1987: 79: 564-6.
  • Wilson R. Influenza vaccination. Thorax 1994: 49: 1079.80.
  • Chaloupka 1. Schuler A, Marschall M. Meier-Ewert H.Comparative analysis of six european influenza vaccines. Eur J Clin Microbiol Infect Dis 1996: 15: 121-7
  • L ..S. Department of Health and Human Services. Public Health Service-Centers for Disease Control and Prevention. Prevention and control of influenza, recommendations of the advisory committee on immunization practices (ACIP). Morb Mortal Wkly Rep (MMWR) 1997; 46(RR-9): 1- 16.
  • Gardner P. Schaffner W. Imtnunization of adults. N Engl J Med 1993: 328(17): 1252-8.
  • Moslow SR, Cate TR. Ruhen FL. Prevention of influenza and pneumonia. Am Rev Respir Dis 1990: 142: 487-8.
  • Nichol KL, Margolis KL. Wuorenma RNJ. Von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N lingl J Med 1994: 331(12): 778-84.
  • Glathe H. Lange W. Influenza vaccination in older patients. lmmunogenicity. epidemiology and available agents. Drugs Aging 1995: 6(51: 368-87.
  • Tamura SI, Kurata H, Funuto H, Nagamine T. Aizawa C. Kurata T. Protection against influenza virus infection by a two-dose regimen of nasal vaccination using vaccines combined with cholera toxin B subunit. Vaccine 1989; 7: 314 20.
  • Fedson DS. Wajda A. Nicol JP. Hammond GW. Kaiser DL, Roos LL. Clinical effectiveness of influenza vaccination in Manitoba. JAMA 1993; 270(16): 1956 61.
  • Descamps B, Chatenoud L, Effects on the immune response. In: Cameron S. Davison AM. Grünfeld JP. Ken DN. Ritz R, Winearls CG. eds. Oxford Textbook of Clinical Nephrology. 2nd ed. New York: Oxford University Press 1998: 1982 -9.
  • Johnson DW. Fleming SJ. The use of vaccines in renal failure. Clin Pharmacokinet 1992: 22(6): 434-46.
  • Kreft B. Klouche M. Kreft R. Kirchner H. Sack K. Low efticiency of active immunization against diphtheria in chronic hemodialysis patients. Kidney Int 1997: 52:212 6.
  • Remuzzi G. Rossi EC, Hematologic consequences of renal failure. In: Brenner BM. ed. The Kidney. 5th ed. USA: W. B. Suunders Company: 1996: 2170-86.
  • Bargman JM, Oreopulos DG. Complications other than peritonitis or those related to the catheter and the fate of uremic organ dysfunction in patients receiving peritoneal dialysis. In: Nolph KD, ed. Peritoneal Dialysis. 3rd ed. Netherlands: Kluwer Academic Publishers: 1990: 289310.
  • Danovitch GM. Immunosuppressive medications and protocols for kidney transplantation. In: Danovitch GM. ed. Handbook of Kidney Transplantation. 3rd ed. USA: Lippincott Williams and Wilkins: 2000: 62-111.
  • Peter WL. Clark JL. Levos OM. Drug therapy in haemodialysis patients. Special considerations in the elderly. Drugs Aging 1998; 12(6): 441 59.
  • Rautenberg P, Teifke . Schlegelberger T. Ullmann L.Influenza subtype-spceitic IgA. JgM. and IgG responses in patients on hemodialysis after influenza vaccination. Infection 1988: 16: 322 8.
  • Zei T. Neri M. Iorio A.M. Immunogenicity of trivalent subunit and split influenza vaccines (1989-90 winter season) in volunteers of different groups of age Vaccine 1991:9: 613-6.
  • Nicholson KG. Snacken K. Palache AM. Iniluenza immunization policies in Europe and the United States. Vaccine 1995: 13(4): 365-9.
  • Berry BB. Murthy VS. Exceeding the healthy people 2000 goal for influenza vaccination through a collaborative effort at eight primary care clinics. Wis Med J 95(10): 705-10.
  • Heilman C, Montagne JR. Influenza: Status and prospects for its prevention, therapy, and control. Pedial Clin North Am 1990; 37(3): 669-81.
  • Suki WN, Eknoyan G. Pathophysiology and clinical manifestations of chronic renal failure and the uremic syndrome. In: Jacohson HR. Striker GE. Klahr S. eds. The Principles and Practice of Nephrology. 2nd ed. USA: Mosby 1995: 603-20.
  • Dogliani M. Fidelio T. Scalzo B. et al. Effectiveness of influenza vaccination in patients undergoing regular dialysis treatments. Minerva Ural Nefrol 1997: 49(3): 12M.
  • Fuchshuber A. Kühnemund O, Lütticken R. Michalk D. Quertfield U, Pneumococcal vaccine in children and young adults with chronic renal disease. Nephrol Dial Transplant 1996; 11: 468 -73.
  • Fedson DS Pneumococeal vaccination in the United States and 20 other developed countries. 1981 1996. Clin Infect Dis 1998: 26: 1117-23.
  • Tolkoff-Rubin NE. Rubin RH. Infection in renal transplant patient. In: Jacohson HR. Striker GE. Klahr S. eds. The Principles and Practice of Nephrology. 2nd ed. USA: Mosby 1995; 826- 33.
  • Blumberg EA. Albano C. Pruett T. et al. The immunogenicity of influenza virus vaccine in solid organ transplant recipients. Clin Infect Dis 1996: 22: 295 302.
  • Briggs WA. Rozek RJ. Migdal SD. et al. Influenza vaccination in kidney transplant recipients: cellular and humoral immune responses Ann Intern Med 1980: 92: 471-7.
  • Nikoskelaincn J. Vaananen P. Forsslrom J, Kasanen A. Influenza vaccination in patients with chronic renal failure. Scand J Infect Dis 1982: 14(4): 245 51.
  • Osonloo EO. Berlin BS. Popli S. et al Antibody responses to influenza vaccination in patients with chronic renal failure. Kidney lnt 1978: 14(6): 614-618.
  • Mitwalli A. Responsiveness to hepatitis to vaccine in inimunocompromised patients by doubling the dose scheduling. Nephron 1996: 73(3):417-20.
  • Keren G. Segev S. Morag A. Zakay Rones Z. Borzilai A. Rubinstein E. Failure of influenza vaccination in the aged. J Med Virol 1988: 25: 85--9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.